Point72 (DIFC) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$44.7M |
| 2 |
Microsoft
MSFT
|
+$41.9M |
| 3 |
Boston Scientific
BSX
|
+$27.2M |
| 4 |
Visa
V
|
+$26.6M |
| 5 |
TSMC
TSM
|
+$25.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$30.4M |
| 2 |
Analog Devices
ADI
|
+$24.4M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$24.4M |
| 4 |
GE Aerospace
GE
|
+$22.9M |
| 5 |
Lam Research
LRCX
|
+$21.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.12% |
| 2 | Technology | 23.11% |
| 3 | Financials | 13.26% |
| 4 | Communication Services | 8.27% |
| 5 | Consumer Discretionary | 7.57% |
No holdings matched the selected filter criteria.
Similar funds
Point72 (DIFC)'s Q3 2025 Portfolio in Review
As of Q3 2025, Point72 (DIFC) held 1,997 positions worth $1.53B, down 42% from $2.64B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Point72 (DIFC) deployed $151M of net new capital in Q3 2025, opening 503 new positions and adding to 228 existing holdings. Its largest new stake was Visa: 76,800 shares worth $26.2M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Analog Devices, an estimated $24.4M trimmed.
- Point72 (DIFC)'s largest Q3 2025 buy was Visa: 76,800 shares worth $26.2M.
- Point72 (DIFC) added most to Meta Platforms (Facebook) in Q3 2025, an estimated $44.7M increase.
- Point72 (DIFC)'s biggest Q3 2025 reduction was Analog Devices, cutting an estimated $24.4M.
- Point72 (DIFC) fully exited NVIDIA in Q3 2025, selling an estimated $30.4M.
- Point72 (DIFC)'s ten largest holdings make up 25% of its $1.53B portfolio in Q3 2025.
- Point72 (DIFC) opened 503 new positions and closed 880 in Q3 2025.
- Point72 (DIFC)'s portfolio value fell 42% quarter-over-quarter to $1.53B.
Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.